These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 27799810)

  • 21. Living-Donor Liver Transplantation for Late-Onset Lysosomal Acid Lipase Deficiency.
    Ramakrishna SH; Kasala MB; Perumal K; Malleeswaran S; Patcha RV; Varghese J
    J Clin Exp Hepatol; 2022; 12(2):672-676. PubMed ID: 35535100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sebelipase alfa: enzymatic replacement treatment for lysosomal acid lipase deficiency.
    Paton DM
    Drugs Today (Barc); 2016 May; 52(5):287-93. PubMed ID: 27376161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early onset lysosomal acid lipase deficiency presenting as secondary hemophagocytic lymphohistiocytosis: Two infants treated with sebelipase alfa.
    Santos Silva E; Klaudel-Dreszler M; Bakuła A; Oliva T; Sousa T; Fernandes PC; Tylki-Szymańska A; Kamenets E; Martins E; Socha P
    Clin Res Hepatol Gastroenterol; 2018 Oct; 42(5):e77-e82. PubMed ID: 29705274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sebelipase alfa: first global approval.
    Shirley M
    Drugs; 2015 Nov; 75(16):1935-40. PubMed ID: 26452566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Disturbance of lipid homeostasis in lysosomal lipase deficiency – pathomechanism, diagnosis and treatment].
    Lipiński P; Tylki-Szymańska A
    Postepy Biochem; 2021 Sep; 67(3):231-235. PubMed ID: 34894393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety of sebelipase alfa for the treatment of lysosomal acid lipase deficiency.
    Ezgü F
    Expert Opin Drug Saf; 2022 Feb; 21(2):149-155. PubMed ID: 34664536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sebelipase alfa enzyme replacement therapy in Wolman disease: a nationwide cohort with up to ten years of follow-up.
    Demaret T; Lacaille F; Wicker C; Arnoux JB; Bouchereau J; Belloche C; Gitiaux C; Grevent D; Broissand C; Adjaoud D; Abi Warde MT; Plantaz D; Bekri S; de Lonlay P; Brassier A
    Orphanet J Rare Dis; 2021 Dec; 16(1):507. PubMed ID: 34906190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lysosomal acid lipase deficiency: wolman disease and cholesteryl ester storage disease.
    Tylki-Szymańska A; Jurecka A
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2014; 35(1):99-106. PubMed ID: 24798600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lysosomal Acid Lipase Deficiency: Therapeutic Options.
    Pastores GM; Hughes DA
    Drug Des Devel Ther; 2020; 14():591-601. PubMed ID: 32103901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular and clinical characterization of a series of patients with childhood-onset lysosomal acid lipase deficiency. Retrospective investigations, follow-up and detection of two novel LIPA pathogenic variants.
    Pisciotta L; Tozzi G; Travaglini L; Taurisano R; Lucchi T; Indolfi G; Papadia F; Di Rocco M; D'Antiga L; Crock P; Vora K; Nightingale S; Michelakakis H; Garoufi A; Lykopoulou L; Bertolini S; Calandra S
    Atherosclerosis; 2017 Oct; 265():124-132. PubMed ID: 28881270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Case series of sebelipase alfa hypersensitivity reactions and successful sebelipase alfa rapid desensitization.
    Huffaker MF; Liu AY; Enns GM; Vijay S; Amor AJ; Adkinson NF
    JIMD Rep; 2019 Sep; 49(1):30-36. PubMed ID: 31497479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-Term Sebelipase Alfa Treatment in Children and Adults With Lysosomal Acid Lipase Deficiency.
    Burton BK; Sanchez AC; Kostyleva M; Martins AM; Marulkar S; Abel F; Barić I
    J Pediatr Gastroenterol Nutr; 2022 Jun; 74(6):757-764. PubMed ID: 35442238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Case of Lysosomal Acid Lipase Deficiency Confirmed by Response to Sebelipase Alfa Therapy.
    Shen JJ; Davis JL; Hong X; Laningham FH; Gelb MH; Kim GE
    J Pediatr Gastroenterol Nutr; 2020 Dec; 71(6):726-730. PubMed ID: 32740531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early diagnosis and successful long-term management of a rare, severe lysosomal acid lipase deficiency/Wolman disease patient: Infancy to age five.
    Cossette A; Castilloux J; Bouffard C; Laflamme J; Faure C; Benlamlih S; Abel F; Beecroft M; Francis M; Drouin R
    Can Liver J; 2022 Aug; 5(3):428-434. PubMed ID: 36133901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Initial assessment and ongoing monitoring of lysosomal acid lipase deficiency in children and adults: Consensus recommendations from an international collaborative working group.
    Kohli R; Ratziu V; Fiel MI; Waldmann E; Wilson DP; Balwani M
    Mol Genet Metab; 2020 Feb; 129(2):59-66. PubMed ID: 31767214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Twice weekly dosing with Sebelipase alfa (Kanuma®) rescues severely ill infants with Wolman disease.
    de Castro MJ; Jones SA; de Las Heras J; Sánchez-Pintos P; Couce ML; Colón C; Crujeiras P; Unceta M; Church H; Brammeier K; Yee WH; Cooper J; López de Frutos L; Serrano-Gonzalo I; Camba MJ; White FJ; Holmes V; Ghosh A
    Orphanet J Rare Dis; 2024 Jun; 19(1):244. PubMed ID: 38918870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lysosomal acid lipase deficiency: diagnosis and treatment of Wolman and Cholesteryl Ester Storage Diseases.
    Porto AF
    Pediatr Endocrinol Rev; 2014 Sep; 12 Suppl 1():125-32. PubMed ID: 25345094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 15-Year progression to liver cancer in the lack of treatment for lysosomal acid lipase deficiency: A case report.
    Cunha-Silva M; de França EVC; Veiga CT; Greca RD; de Moraes PBS; de Campos Mazo DF; de Ataíde EC; Perales SR; Monici LT; Sevá-Pereira T
    Medicine (Baltimore); 2022 Sep; 101(35):e30315. PubMed ID: 36107601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnosis, treatment, and follow-up of a case of Wolman disease with hemophagocytic lymphohistiocytosis.
    Baronio F; Conti F; Miniaci A; Carfagnini F; Di Natale V; Di Donato G; Testi M; Totaro C; De Fanti A; Boenzi S; Dionisi-Vici C; Esposito S; Pession A
    Mol Genet Metab Rep; 2022 Mar; 30():100833. PubMed ID: 35242567
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.